Levothyroxine Sodium Tablet
Product Images NDC 51655-544

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-544). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 544 52)

Label (51655 544 52)
Label for Levothyroxine Sodium Tablets, USP 100 mcg (0.1 mg) in oral tablet form. The package contains 30 tablets and is labeled for prescription use only. The label includes storage instructions and mentions Northwind Pharmaceuticals as the repackager, with lot and expiration details also noted.*
FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Levothyroixe Molecule (Levothyroxine Molecule)
Chemical structure diagram of Levothyroxine Sodium showing its molecular components, including iodine atoms, hydroxyl group, ether linkage, and sodium carboxylate with associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.